Medigene AG at its AGM three new members were elected in a supplemental election to the company's Supervisory Board which now increased to six members: Keith Manchester, Managing Director and Head at Life Sciences QVT Financial LP, USA; Ronald Scott, Chief Executive Officer of Basilea Pharmaceutical International Ltd., Switzerland; and Dr. Gerd Zettlmeissl, self-employed consultant.